Marsh reports third-quarter growth for Marsh & McLennan stock

Published on 10/21/2026 at 11:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings per share rose 10.00 percent to USD 2.03 in the third quarter of 2026. Marsh & McLennan stock costs EUR 170.73 on October 21, 2026, 0.61 percent above the Xetra close.

Quarterly growth and target changes

Marsh reported 8.00 percent revenue growth for the third quarter on October 15, 2026.
Adjusted earnings per share reached USD 2.03 in the third quarter of 2026, up 10.00 percent.
Marsh & McLennan stock trades at EUR 170.73 at 11:48 a.m. CEST at Lang & Schwarz on October 21, 2026, 0.61 percent above the Xetra close of October 20, 2026.

Pop-Art-Comic zeigt Handschlag zwischen Berater und Kunde mit Sprechblase DEAL — Marsh & McLennan (ISIN US5717481023) als farbenfrohe Pop-Art-Comic-Szene eines Versicherungsberaters beim Vertragsabschluss, Illustration mit AI erstellt.

Marsh & McLennan (ISIN US5717481023) was trading at EUR 170.73 at Lang & Schwarz on October 21, 2026, at 11:48 a.m. CEST, 0.61 percent above the Xetra close of October 20, 2026 at EUR 169.70. The latest results showed 8.00 percent revenue growth and a 10.00 percent increase in adjusted earnings per share.

Third-quarter results set the context

According to Morningstar on October 15, 2026, Marsh reported third-quarter revenue of USD 6.9 billion, up 8.00 percent from the prior-year quarter. Underlying revenue growth was 5.00 percent, while adjusted operating income increased 6.00 percent to USD 1.5 billion.

The earnings mix was uneven. Consulting revenue increased 9.00 percent to USD 2.7 billion, and Management Consulting revenue rose 14.00 percent. Reinsurance revenue declined 6.00 percent to USD 374.00 million, highlighting pressure in property reinsurance pricing.

What changed across three dates

On October 15, 2026, Marsh reported USD 6.9 billion of third-quarter revenue and adjusted earnings per share of USD 2.03, according to Morningstar. On October 20, 2026, Mizuho raised its price target from USD 190.00 to USD 200.00, while on October 21, 2026, JPMorgan raised its target from USD 215.00 to USD 218.00, according to StockAnalysis.

The target changes frame the stock against two different readings of the results. Growth in consulting and adjusted earnings supports the expansion case, but the 6.00 percent reinsurance revenue decline shows why insurance pricing remains a counterweight.

Stock stays above the Xetra close

Marsh & McLennan has a market capitalization of USD 91.3 billion as of October 20, 2026, based on the NYSE-listed MRSH share. The company operates in insurance broking and advises clients across risk, reinsurance and capital, people and investments, and management consulting.

At Lang & Schwarz, Marsh & McLennan was trading at EUR 170.73 on October 21, 2026, at 11:48 a.m. CEST, 0.61 percent above the Xetra close of October 20, 2026 at EUR 169.70. The further course of trading is shown by the continuously updated real-time quote of Marsh & McLennan stock.